1. Home
  2. GNTA vs RAND Comparison

GNTA vs RAND Comparison

Compare GNTA & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTA
  • RAND
  • Stock Information
  • Founded
  • GNTA 2014
  • RAND 1969
  • Country
  • GNTA Italy
  • RAND United States
  • Employees
  • GNTA N/A
  • RAND N/A
  • Industry
  • GNTA Biotechnology: Biological Products (No Diagnostic Substances)
  • RAND Finance: Consumer Services
  • Sector
  • GNTA Health Care
  • RAND Finance
  • Exchange
  • GNTA Nasdaq
  • RAND Nasdaq
  • Market Cap
  • GNTA 71.9M
  • RAND 80.9M
  • IPO Year
  • GNTA 2021
  • RAND N/A
  • Fundamental
  • Price
  • GNTA $3.96
  • RAND $28.10
  • Analyst Decision
  • GNTA Strong Buy
  • RAND
  • Analyst Count
  • GNTA 1
  • RAND 0
  • Target Price
  • GNTA $25.00
  • RAND N/A
  • AVG Volume (30 Days)
  • GNTA 5.4K
  • RAND 17.6K
  • Earning Date
  • GNTA 01-01-0001
  • RAND 03-04-2025
  • Dividend Yield
  • GNTA N/A
  • RAND 17.90%
  • EPS Growth
  • GNTA N/A
  • RAND 123.39
  • EPS
  • GNTA N/A
  • RAND 4.98
  • Revenue
  • GNTA N/A
  • RAND $8,351,941.00
  • Revenue This Year
  • GNTA N/A
  • RAND N/A
  • Revenue Next Year
  • GNTA N/A
  • RAND N/A
  • P/E Ratio
  • GNTA N/A
  • RAND $5.64
  • Revenue Growth
  • GNTA N/A
  • RAND 16.96
  • 52 Week Low
  • GNTA $2.20
  • RAND $13.69
  • 52 Week High
  • GNTA $7.28
  • RAND $31.89
  • Technical
  • Relative Strength Index (RSI)
  • GNTA 47.29
  • RAND 78.59
  • Support Level
  • GNTA $3.76
  • RAND $22.77
  • Resistance Level
  • GNTA $4.13
  • RAND $28.00
  • Average True Range (ATR)
  • GNTA 0.29
  • RAND 1.67
  • MACD
  • GNTA 0.04
  • RAND 0.42
  • Stochastic Oscillator
  • GNTA 34.29
  • RAND 61.64

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.

Share on Social Networks: